Professor, Surgery, UCSF School of Medicine
Vascular Surgery
Dr. Michael Conte, MD
|
|
Give Review
Michael Conte is an expert in the field of Vascular Surgery. He went to Albert Einstein College of Medicine of Yeshiva University. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". Michael Conte, MD is a published physician. He has 98 papers published. The most current publication "Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy." Michael Conte accepts Medicare.
Publications
- Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after Carotid endarterectomy.
- NonreVascularization-based treatments in patients with severe or critical limb ischemia.
- The Vascular surgeon-scientist: A 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development A...
- Outcomes of neuroIschemic wounds treated by a multidisciplinary amputation prevention service.
- Primary stenting in femoropopliteal occlusive Diseaseã- what is the appropriate role?
- Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: Consensus Definitions From Peripheral Academic Research Consortium (PARC).
- Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
- Society for Vascular Surgery practice guidelines for atherosclerotic occlusive Disease of the lower extremities: Management of asymptomatic Disease and claudication.
- Advancing beyond the "heart-healthy diet" for peripheral arterial Disease.
- Relationship between kidney disease and endothelial function in peripheral Artery disease.
- Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the ClinicalTrials.gov Database.
- Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial Disease.
- Short-term physical inactivity impairs Vascular function.
- Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal Disease.
- Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal Artery following endovascular revascularization.
- Factors associated with primary Vein graft occlusion in a multicenter trial with mandated ultrasound surveillance.
- Adventitial Nab-Rapamycin Injection Reduces Porcine Femoral Artery Luminal Stenosis Induced by Balloon Angioplasty via Inhibition of Medial Proliferation and Adventiti...
- The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI).
- Vein graft failure.
- n-3 Polyunsaturated fatty acids supplementation in peripheral Artery disease: the OMEGA-PAD trial.
- Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.
- Peripheral Artery disease and risk of cardiovascular events in patients with coronary Artery disease: Insights from the Heart and Soul Study.
- Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL).
- Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive Disease.
- Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral Artery disease.
- Proceedings from the society of interventional radiology research consensus panel on critical limb ischemia.
- Effects of Gravitational Mechanical Unloading in Endothelial Cells: Association between Caveolins, Inflammation and Adhesion Molecules.
- D-series resolvins attenuate Vascular smooth muscle cell activation and neointimal hyperplasia following Vascular injury.
- Critical appraisal of surgical reVascularization for critical limb ischemia.
- A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity Vein bypass grafts.
- Thirty-day Vein remodeling is predictive of midterm graft patency after lower extremity bypass.
- Mitochondrial heat shock protein-90 modulates Vascular smooth muscle cell survival and the Vascular injury response in vivo.
- Medical Management of Peripheral Arterial Disease: Bridging the "Gap"?
- Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity Vein bypass grafts.
- Diabetic reVascularization: endoVascular versus open bypass-do we have the answer?
- RNAi-Mediated Survivin Gene Knockdown Induces Growth Arrest and Reduced Migration of Vascular Smooth Muscle Cells.
- Influence of diabetes and perivascular allogeneic endothelial cell implants on arterioVenous fistula remodeling.
- Mineralocorticoid receptor (MR) expression in human venous smooth muscle cells: A potential role for aldosterone signaling in Vein graft arterialization.
- Regarding "Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial Disease (CASPAR) trial".
- Erratum to: Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients.
- Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients.
- Discussion. Open surgical reVascularization for wound healing: past performance and future directions; and Critical evaluation of endoVascular surgery for limb salvage.
- Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral Atherosclerosis.
- Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
- Understanding objective performance goals for critical limb ischemia trials.
- Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral Vein bypass grafts.
- Critical limb ischemia.
- Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous Vein.
- Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
- Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arterioVenous access for hemodialysis use: the V-HEALTH study.
- Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
- Technical factors in lower-extremity Vein bypass surgery: how can we improve outcomes?
- Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
- Surgical reVascularization. Introduction.
- In vivo human lower extremity saphenous Vein bypass grafts manifest flow mediated vasodilation.
- In vivo differentiation of two vessel wall layers in lower extremity peripheral Vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE.
- Under-representation of women and ethnic minorities in Vascular surgery randomized controlled trials.
- Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage.
- Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open Abdominal aortic aneurysm repair.
- Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of Vein graft failure and limb loss.
- Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
- Comparison of costs of staged versus simultaneous lower extremity Arterial hybrid procedures.
- C-reactive protein and Vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.
- Risk factors for failure of lower-extremity reVascularization procedures: are they different for bypass and percutaneous procedures?
- Early remodeling of lower extremity Vein grafts: inflammation influences biomechanical adaptation.
- Lower extremity peripheral Vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner v...
- Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
- High-resolution peripheral Vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE.
- Buflomedil in peripheral arterial Disease: trials and tribulations.
- Clinical results of Carotid artery stenting compared with Carotid endarterectomy.
- Female gender and oral anticoagulants are associated with wound complications in lower extremity Vein bypass: an analysis of 1404 operations for critical limb ischemia.
- Technical factors affecting autogenous Vein graft failure: observations from a large multicenter trial.
- Surgical and endovascular revision of infrainguinal Vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial.
- Restenosis after Carotid endarterectomy performed with routine intraoperative duplex ultrasonography and arterial patch closure: a contemporary series.
- Molecular engineering of Vein bypass grafts.
- Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney Disease classification.
- Superficial femoral Artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts.
- Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in Vein bypass.
- Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity Vein bypass surgery.
- Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.
- Early biomechanical changes in lower extremity Vein grafts--distinct temporal phases of remodeling and wall stiffness.
- Survivin regulation of Vascular injury.
- Lower-extremity arterial Disease.
- Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage.
- Regulation of Vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.
- Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
- Survivin expression is up-regulated in Vascular injury and identifies a distinct cellular phenotype.
- Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal Vein graft failure.
- Gene therapy for the extension of Vein graft patency: a review.
- Infrainguinal Vein bypass graft revision: factors affecting long-term outcome.
- Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of Vascular contraction.
- Carotid endarterectomy: who is the high-risk patient?
- Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.
- Thoracovisceral segment aneurysm repair after previous infrarenal Abdominal aortic aneurysm surgery.
- Early adaptation of human lower extremity Vein grafts: wall stiffness changes accompany geometric remodeling.
- The impact of patient age and Aortic size on the results of aortobifemoral bypass grafting.
- Preoperative risk factors for Carotid endarterectomy: defining the patient at high risk.
Schools
Albert Einstein College of Medicine of Yeshiva University
Ny Hospcornell Med Center
Brigham and Women39s Hospital
Procedures Preformed
- Aortic Repair, Open or Repair of Arterial Aneurysm, Open
- ArterioVenous Shunt Creation
- Carotid Endarterectomy (CEA) or Excision of Infected Graft
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- View All
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Acute Deep Vein Thrombosis (DVT)
- Acute Venous Embolism Thrombosis
- Aortic Aneurysm
- View All
Doctors Specialties
- General Surgery
- Vascular Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
Brigham and Women's Hospital -
New York Presbyterian Hospital - Cornell Campus -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
San Francisco VA Medical Center -
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1417993247 | |
| NPPES Provider LastName | CONTE | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 941430222 | |
| NPPES Provider State | CA | |
| Specialty Description | Vascular Surgery | |
| Total Claim Count | 117.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417993247 |
| Last Name Of The Provider | CONTE |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
Dr. Yolanda L. Vea, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel R. Nathanson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shant M. Vartanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cherrie Z. Abraham, MD |
|
|
Dr. Lawrence B. Oresanya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheela T. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel G. McGrath, DO |